TABLE 1.
Baseline characteristics of the 30 patients who completed the protocol
| Characteristic | Value for:
|
|
|---|---|---|
| Group I (active) | Group II (placebo) | |
| Total no. (%) | 16 (100) | 14 (100) |
| Age | ||
| 5-15 yr | 4 (25) | 10 (71.4) |
| >15-50 yr | 6 (37.5) | 1 (7.1) |
| >50 yr | 6 (37.5) | 3 (21.4) |
| Median (yr) | 40 | 14 |
| Range (yr) | 9-90 | 5-65 |
| Sex | ||
| Male | 8 (50.0) | 5 (35.7) |
| Female | 8 (50.0) | 9 (64.3) |
| Duration of ulcer | ||
| <1 yr | 8 (50) | 11 (78.6) |
| ≥1 yr | 8 (50) | 3 (21.4) |
| Site of lesion | ||
| Upper limb | 2 (12.5) | 3 (21.4) |
| Lower limb | 14 (87.5) | 9 (64.3) |
| Trunk | 0 (0.0) | 2 (14.3) |
| Baseline surface area of ulcer (cm2) | ||
| Mean ± SE | 28.6 ± 5.6 | 15.3 ± 3.1 |
| Median | 22.3 | 15.2 |
| Range | 0.9-69.3 | 1.0-37.8 |
| Treatment prior to enrollment in study | ||
| Eusol dressings | 10 (62.5) | 12 (85.7) |
| Topical antibiotic (metronidazole or penicillin) | 2 (12.5) | 1 (7.1) |
| Topical herbs | 0 | 1 (7.1) |
| Not known | 4 (25) | 0 |